Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan
Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection…
Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection…
NEW DELHI–(BUSINESS WIRE)–Wavin B.V., a global solutions leader for the Building and Infrastructure industry and…
VANCOUVER, BC / ACCESSWIRE / December 24, 2021 / Empress Royalty Corp. (TSXV:EMPR)(OTCQB:EMPYF) (“Empress Royalty”…
TORONTO, ON / ACCESSWIRE / December 24, 2021 / Monterey Minerals Inc. (the “Company” or…
TORONTO, ON / ACCESSWIRE / December 24, 2021 / Li-Metal Corp. (CSE:LIM)(FSE:5ZO) (“Li-Metal” or the…
Not for release to US wire services or distribution in the United States ANNOUNCEMENT TO…
VANCOUVER, BC / ACCESSWIRE / December 24, 2021 / Imagine a world in which one…
BRISBANE, AUSTRALIA / ACCESSWIRE / December 24, 2021 / Ritestream is a revolutionary platform for…
LONDON, UK / ACCESSWIRE / December 24, 2021 / Love Hemp Group PLC (AQSE:LIFE) (OTCQB:WRHLF),…
NEW YORK, NY / ACCESSWIRE / December 24, 2021 / There aren’t many subjects more…
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible…
TOKYO, Japan and CAMBRIDGE, United Kingdom, Dec. 23, 2021 (GLOBE NEWSWIRE) — Sosei Group Corporation…
DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering…
– Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and…
FLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible…
Saint Herblain (France), December 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants. Rethink-ALZ.com…
FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22,…
– Topline results from pivotal SEAL study expected in Q1 2022 – If approved, ADAIR…